Please login to the form below

Not currently logged in
Email:
Password:

EMA appoints Luc Vanheel as head of administration

He joins with immediate effect
Luc Vanheel

The European Medicines Agency (EMA) has named Luc Vanheel as the new head of its administration division.

Vanheel has previously worked as finance and business services director and deputy director and head of plans and programmes at the European Aviation Safety Agency (EASA), where he worked for six years.

He also worked his way from management reporting controller to a managing director over a 24-year period at Anheuser-Busch InBev, the world's largest brewer.

Deputy executive director Andreas Pott said: “EMA considers itself lucky to have gained Luc Vanheel as a new colleague and Head of Administration. Luc has ample managerial experience in both major private companies and in the European public sector. We are reassured that the challenging services he is taking over will be in good hands and that he will develop his vision of a modern, streamlined and ever more efficient administration.”

Vanheel will bring 30 years of experience in business administration in both the public and private sectors to the role, with a strong background in resource management, support services, strategic and budgetary planning and reporting.

Throughout his career, Vanheel has lived and worked in seven countries including Russia, Japan, Croatia, Belgium and Germany.

24th November 2014

From: Regulatory

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....
Could formulary intelligence be your brand differentiator?
Proprietary research, and the COVID-19 experience, shows how formulary intelligence can drive competitive advantage at launch...
Lara Meyer
How COVID-19 is accelerating the threat of antimicrobial resistance
Why antimicrobial resistance needs to be addressed with the same urgency as COVID-19...

Infographics